Literature DB >> 17460476

Early virologic failure in HIV-coinfected hepatitis C patients treated with the peginterferon-ribavirin combination: does abacavir play a role?

Firouzé Bani-Sadr, Lise Denoeud, Patrice Morand, Françoise Lunel-Fabiani, Stanislas Pol, Patrice Cacoub, Christian Perronne, Fabrice Carrat.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17460476     DOI： 10.1097/QAI.0b013e318040b2b6

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  17 in total

1.  Plasma and intracellular ribavirin concentrations are not significantly altered by abacavir in hepatitis C virus-infected patients.

Authors:  Edward J Fuchs; Jennifer J Kiser; Craig W Hendrix; Mark Sulkowski; Christine Radebaugh; Lane Bushman; Michelle L Ray; Adriana Andrade
Journal:  J Antimicrob Chemother       Date:  2016-02-10       Impact factor: 5.790

Review 2.  Coinfection with hepatitis C virus and human immunodeficiency virus: virological, immunological, and clinical outcomes.

Authors:  Yaron Rotman; T Jake Liang
Journal:  J Virol       Date:  2009-05-06       Impact factor: 5.103

3.  Challenges in initiating antiretroviral therapy in 2010.

Authors:  Cécile L Tremblay; Jean-Guy Baril; David Fletcher; Donald Kilby; Paul Macpherson; Stephen D Shafran; Mark W Tyndall
Journal:  Can J Infect Dis Med Microbiol       Date:  2010-08       Impact factor: 2.471

Review 4.  What the infectious disease physician needs to know about pegylated interferon and ribavirin.

Authors:  Naveen Gara; Marc G Ghany
Journal:  Clin Infect Dis       Date:  2013-02-21       Impact factor: 9.079

Review 5.  Abacavir/lamivudine fixed-dose combination antiretroviral therapy for the treatment of HIV.

Authors:  Chad J Achenbach; Kimberly K Scarsi; Robert L Murphy
Journal:  Adv Ther       Date:  2010-03-05       Impact factor: 3.845

Review 6.  Liver disease in the HIV-infected individual.

Authors:  Jennifer C Price; Chloe L Thio
Journal:  Clin Gastroenterol Hepatol       Date:  2010-09-17       Impact factor: 11.382

Review 7.  Antiviral drugs and the treatment of hepatitis C.

Authors:  Ziba Jalali; Jürgen K Rockstroh
Journal:  Curr HIV/AIDS Rep       Date:  2012-06       Impact factor: 5.071

Review 8.  Management complexities of HIV/hepatitis C virus coinfection in the twenty-first century.

Authors:  Vincent Lo Re; Jay R Kostman; Valerianna K Amorosa
Journal:  Clin Liver Dis       Date:  2008-08       Impact factor: 6.126

Review 9.  Management of hepatitis B virus co-infection on and off antiretroviral therapy.

Authors:  Vincent Soriano; Eugenia Vispo; Marcelle Bottecchia; Julie Sheldon; Paula Tuma; Javier Garcia-Samaniego; Pablo Barreiro
Journal:  Curr HIV/AIDS Rep       Date:  2008-05       Impact factor: 5.071

10.  PharmGKB summary: abacavir pathway.

Authors:  Julia M Barbarino; Deanna L Kroetz; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2014-05       Impact factor: 2.089
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.